Latest / The Purposeful Strategist
Bringing Immunotherapy “Far On”
In this episode of The Purposeful Strategist, Belden Menkus speaks with Juho Jalkanen, CEO of Faron, a biotechnology company on a mission to bring cutting-edge immunotherapy to as many patients as possible, currently focused on difficult-to-treat cancers.
In their conversation, they discuss:
· How immunotherapy uses the patient's own immune system to attack disease, and why that makes it such a promising treatment.
· Faron's business strategy, rooted in absorbing the financial risk of scientific research, and how they keep pharmaceutical partners updated as they "de-risk" the product through…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.